Cargando…
Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia
Unusual forms of pulmonary hypertension include pulmonary hypertension related to mediastinal fibrosis and the use of serotonergic drugs. Here, we describe a patient with diffuse mediastinal fibrosis and pulmonary hypertension while she was on dopamine agonist therapy. A young woman, who was treated...
Autores principales: | Su, Junjing, Simonsen, Ulf, Carlsen, Jørn, Mellemkjaer, Soren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517450/ https://www.ncbi.nlm.nih.gov/pubmed/28775691 http://dx.doi.org/10.3389/fphar.2017.00492 |
Ejemplares similares
-
Limited value of pulse wave analysis in assessing arterial wave reflection and stiffness in the pulmonary artery
por: Su, Junjing, et al.
Publicado: (2021) -
Olanzapine-Induced Hyperprolactinemia: Two Case Reports
por: Barata, Pedro Cabral, et al.
Publicado: (2019) -
Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
por: Su, Junjing, et al.
Publicado: (2017) -
The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014) -
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
por: Wu, Tzu-Hua, et al.
Publicado: (2021)